
Gem Aromatics Limited IPO
MAINBOARDGem Aromatics IPO Details
Gem Aromatics IPO Subscription
Gem Aromatics IPO Application Wise Breakup (Approx)
Gem Aromatics IPO Dates
- 19 Aug 2025Opening dateOPD
- 21 Aug 2025Closing dateCOD
- 22 Aug 2025Basis of AllotmentBOA
- 25 Aug 2025Initiation of RefundsIOR
- 25 Aug 2025Credit of SharesCOS
- 26 Aug 2025Listing dateLID
Gem Aromatics IPO Lot Size
Application | Lots | Shares | Amount |
---|---|---|---|
Retain Minimum | 1 | 46 | ₹14,950 |
Retain Maximum | 13 | 598 | ₹194,350 |
SHNI Minimum | 14 | 644 | ₹209,300 |
SHNI Maximum | 66 | 3036 | ₹986,700 |
BHNI Minimum | 67 | 3082 | ₹1,001,650 |
Gem Aromatics IPO Reservation
Promoter Holding
Gem Aromatics IPO Valuations
Gem Aromatics Limited Financial Information
Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
Assets | 534.52 | 368.57 | 295.76 |
Total Income | 505.64 | 454.23 | 425.09 |
Profit After Tax | 53.38 | 50.10 | 44.67 |
EBITDA | 88.45 | 78.35 | 66.19 |
Net Worth | 283.98 | 230.55 | 179.53 |
Reserves and Surplus | 278.26 | 224.88 | 182.36 |
Total Borrowing | 222.37 | 111.13 | 89.36 |
Amount in ₹ Crore |
About Gem Aromatics IPO
Incorporated in October 1997, Gem Aromatics Limited manufactures speciality ingredients, including essential oils, aroma chemicals, and Value-Added Derivatives in India, with over two decades of experience. The company offers various products, from Mother Ingredients to Value-Added Derivatives.
The company's products are used in oral care, cosmetics, nutraceuticals, pharmaceuticals, wellness, pain management, and personal care.
The company provides a total of seventy products, categorized into four distinct groups, which include:
- Mint and its derivatives;;
- Clove and its derivatives;
- Phenol; and
- Other synthetic and natural ingredients.
As of September 30, 2024, the company serves 170 domestic customers and 30 international customers across 13 countries, including the Americas, Asia, Africa, and Australia.
The company sells products directly to customers on a business-to-business basis, with export sales through methods including (i) direct sales, (ii) sales via its subsidiary, Gem Aromatics LLC, in the USA, and (iii) sales through third-party agencies.
As of September 30, 2024, the company had an in-house R&D team of 15 scientists who pivotally implemented state-of-the-art technology that advanced our formulations in Value-Added Derivatives.
Strength Of Gem Aromatics IPO
1. Established manufacturer of specialty ingredients, including, essential oils, aroma chemicals and Value-Added Derivatives in India.
2. Wide product range with continuous product development and R&D capabilities.
3. Long standing relationship with well-established customers in India and globally.
4. Strategically located Manufacturing Facilities with focus on sustainability.
5. Experienced Promoters and management team.
Risk Of Gem Aromatics IPO
1. We derive a significant portion of our revenue from our top 10 customers. In Fiscal 2025, we derived 56.06% of our total revenue from operations from our top 10 customers. The loss of any of these customers may adversely affect our revenues and profitability.
2. The company derives a significant portion of its revenue from its top customer doTERRA Global Limited (formerly known as doTERRA GH Ireland Limited) ("doTERRA") with whom the company has entered into a supply agreement, the term of which is ending on December 31, 2028. If doTERRA chooses not to source their requirements from it, there may be a material adverse effect on it business, financial condition, cash flows and results of operations.
3. We derive a substantial portion of our revenue from the mint and mint derivatives product category. In Fiscal 2025, 2024 and 2023, we derived 69.12%, 72.89% and 69.98% of our revenue from operations from the mint and mint derivatives product category. Any reduction in demand for products under the mint and mint derivatives product category may adversely affect our revenues and profitability.
4. The Company is involved in an on-going litigation in the Supreme Court of India with respect to the land on which its Budaun Facility is located. Any adverse outcome in such proceedings may have an adverse effect on its business, results of operations, financial condition and cash flows.
5. One of the entities, Gopinath Dairy Products Private Limited, which is identified as a part of the Promoter Group under the SEBI ICDR Regulations is undergoing liquidation proceedings and accordingly has not provided any information in respect of itself. All information in relation to Gopinath Dairy Products Private Limited included in the DRHP is from publicly available sources. Further, Lallubhai Hargovindas Chitalia, Krishna Lallubhai Chitalia, Rajesh Lallubhai Chitalia, individual members of its Promoter Group, along with Gopinath Dairy Products Private Limited, have been identified as wilful defaulters in their capacity as directors and guarantor of Gopinath Dairy Products Private Limited.
6. The company has not entered into any long-term contracts with its suppliers from whom the company procure raw materials consumed by it for its manufacturing process and failures by the company suppliers to meet their obligations could adversely affect its business, results of operations, financial condition and cash flows.
7. The company does not have firm commitment agreements with majority of its customers. If the company customers choose not to source their requirements from it, there may be a material adverse effect on the company business, financial condition, cash flows and results of operations.
8. The company has significance dependence on its top 10 suppliers for supply of raw materials. In Fiscal 2024, its top 10 suppliers contributed towards 68.61% of the company total expenses. The loss of any of these suppliers or and failures by these suppliers to meet their obligations may adversely affect its revenues and profitability.
9. Increase in costs of raw materials, may impact its revenue from operations and profitability and may result in a materially adverse effect on the company business, results of operations and financial condition.
10. Restrictions on import of raw materials and an increase in shipment cost may adversely impact its business, cash flows and results of operations.
Objectives Gem Aromatics IPO
- Prepayment and/or repayment, in full or in part, of all or a portion of certain outstanding borrowings availed by the Company and its Subsidiary, Krystal Ingredients Private Limited; and
- General corporate purposes.
Company Contact Details
Gem Aromatics Limited
A/410, Kailas Complex, Vikhroli Powai Link
Road, Park Site,
Vikhroli (W)
Mumbai, Maharashtra
Phone: +91 22 25185231
Email: secretarial@gemaromatics.in
Website: http://www.gemaromatics.com/
Registrar Contact Details
Lead Mangers
Lead Manager Reports